Treatment Naive AML
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML) (NCT02203773) | AbbVie | 2014-10-06 |
Track Treatment Naive AML automatically
Every clearance here is in the API, with alerts when new ones post.